Lite Strategy, Inc. Prepaid Expense and Other Assets, Current
Lite Strategy, Inc. (LITS) had Prepaid Expense and Other Assets, Current of $1.35 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-05-13
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.35M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $2.15M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $3.12M.
- 2025-06-30: Prepaid Expense and Other Assets, Current $274.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-03-31 | $1.35M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.15M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $3.12M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $274.00K 10-Q · filed 2026-05-13 | |
| 2025-03-31 | $307.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $646.00K 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $840.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.42M 10-K · filed 2025-09-26 | |
| 2024-03-31 | $2.81M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $6.69M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $6.22M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $6.75M 10-K · filed 2024-09-19 | |
| 2023-03-31 | $3.87M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.57M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $2.78M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.83M 10-K · filed 2023-09-26 | |
| 2022-03-31 | $5.98M 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $4.82M 10-Q/A · filed 2022-05-23 | |
| 2021-09-30 | $3.74M 10-Q/A · filed 2022-05-23 | |
| 2021-06-30 | $3.81M 10-K · filed 2022-09-08 | |
| 2021-03-31 | $11.94M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $13.89M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $7.38M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $2.74M 10-K/A · filed 2022-05-23 | $5.59M 10-K · filed 2020-09-09 |
| 2020-03-31 | $2.60M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.56M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $2.13M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.44M 10-K · filed 2020-09-09 | |
| 2019-03-31 | $3.15M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.42M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $3.67M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.59M 10-K · filed 2019-08-28 | |
| 2018-03-31 | $854.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $772.00K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $641.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.76M 10-K · filed 2018-08-30 | |
| 2017-03-31 | $2.76M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $2.67M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $1.74M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $831.00K 10-K · filed 2017-09-05 | |
| 2016-03-31 | $1.10M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $787.00K 10-Q · filed 2016-02-05 | |
| 2015-09-30 | $596.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $502.00K 10-K · filed 2016-09-06 | |
| 2015-03-31 | $592.00K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $533.00K 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $353.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $497.00K 10-K · filed 2015-09-02 | |
| 2014-03-31 | $861.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $893.00K 10-Q · filed 2014-02-11 | |
| 2013-09-30 | $602.00K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $456.00K 10-K · filed 2014-09-09 | |
| 2013-03-31 | $260.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $197.00K 10-Q · filed 2013-02-12 | |
| 2012-09-30 | $123.00K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $146.00K 10-K · filed 2013-09-18 | |
| 2012-03-31 | $543.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $200.00K 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $108.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $272.00K 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |